Peer review reports
From: Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Original Submission | ||
---|---|---|
26 Sep 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
24 Feb 2023 | Reviewed | Reviewer Report |
29 Mar 2023 | Reviewed | Reviewer Report |
1 May 2023 | Reviewed | Reviewer Report |
25 May 2023 | Author responded | Author comments - Nikolaj Siersbæk |
Resubmission - Version 3 | ||
25 May 2023 | Submitted | Manuscript version 3 |
18 Jun 2023 | Reviewed | Reviewer Report |
18 Jun 2023 | Reviewed | Reviewer Report |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
22 Jun 2023 | Editorially accepted | |
3 Jul 2023 | Article published | 10.1186/s12883-023-03302-7 |